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Abstract
 
Introduction
Breast  cancer  control  efforts  could  benefit  from  esti-
mating  mammography  prevalence  at  the  substate  level 
because  studies  have  primarily  analyzed  health  survey 
data at the national and state levels. The purpose of this 
study was to evaluate the extent to which geographic dis-
parities exist in mammography use across counties in the 
contiguous United States.
 
Methods
We estimated county-level prevalence of recent mam-
mography (past 2 years) for women aged 40 to 79 years by 
using synthetic regression, a small-area estimation meth-
od. The 2000 Behavioral Risk Factor Surveillance System 
(BRFSS),  2000  Census,  Area  Resource  File,  and  Food 
and  Drug  Administration  mammography  facility  data 
were merged by BRFSS respondents’ county of residence. 
We conducted separate analyses to produce county-level 
prevalence estimates for each race and age group.
 
Results
Mammography use varied geographically, and the mag-
nitude of geographic disparities differed by race and age. 
Nonwhite women showed the lowest prevalence of mam-
mography  and  widest  range  in  county-level  estimates. 
Women  aged  40  to  49  had  generally  lower  prevalence 
than other age groups, while women aged 65 to 79 showed 
the  greatest  variation  in  county-level  mammography   
estimates.
 
Conclusions
Small-area  estimation  using  BRFSS  data  is  advanta-
geous for surveillance of mammography use at the county 
level.  This  method  allows  documentation  of  geographic 
disparities and improves our understanding of the spa-
tial  distribution  of  mammography  prevalence.  Future 
interventions should consider this county-level geographic 
variation, targeting women in the neediest counties.
Introduction
 
The Centers for Disease Control and Prevention (CDC) 
designed the Behavioral Risk Factor Surveillance System 
(BRFSS) to produce state-level estimates of risk factors 
and  health  behaviors.  The  BRFSS  collects  information 
about  respondents’  county  of  residence,  making  county-
level analyses possible. Recently, public health practitio-
ners have been interested in obtaining BRFSS data on the 
substate  level;  however,  the  small  county-level  samples 
often  produce  unstable  prevalence  estimates  with  large 
standard  errors.  CDC  recommends  a  minimum  of  50 
observations to reliably estimate prevalence (1).
 
Breast cancer control is a research area that could ben-
efit from estimating prevalence at the substate level. Most 
of the data available on the use of preventive services, like 
mammography, are national and state data, and studies 
have  identified  correlates  of  cancer  screening  on  these 
geographic  levels  by  using  national  health  survey  data 
(2,3).  Research  is  needed  on  subpopulations  defined  by 
geographic units smaller than the state because findings 
from the national or even state level often do not translate 
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to the contextual experience of women on the county or 
neighborhood  level  (4).  Substate  variation  in  mammog-
raphy  prevalence  (5,6)  has  been  found  for  metropolitan 
statistical areas and counties with adequate sample size 
(≥50). Geographic gaps exist in mammography interven-
tions; certain areas disproportionately receive funds and 
outreach (7). Women who are not screened may be concen-
trated in locations with particular screening barriers (8).
 
Data  aggregation  strategies  attempt  to  overcome   
sample-size limitations by combining several years of data 
for 1 county (9) or combining data from several neighbor-
ing counties (3). However, temporal aggregations conceal 
time-trend  differences,  and  spatial  aggregations  limit 
the ability to show interarea differences. An alternative 
method is small-area analysis, a statistical procedure that 
aims to produce stable estimates for areas of inadequate 
sample size. Studies have used various small-area estima-
tion  techniques  to  estimate  prevalence  at  the  substate 
level (10,11). However, a recent study found that synthetic 
multilevel regression produced the most valid prevalence 
estimates (1).
 
The purpose of this study was to apply the synthetic 
regression estimation technique to determine the extent 
to  which  geographic  disparities  exist  in  mammography 
and the extent to which the magnitude and distribution 
of geographic disparities vary by race and age. One of the 
national health objectives related to public health infra-
structure is to ensure that health agencies have the neces-
sary infrastructure by increasing the proportion of leading 
health indicators for which data are available (12). If data 
are not available to state and local public health agencies, 
then health or access problems may not be identified for a 
population or distinct subpopulations of an area (13). Local 
health departments can use small-area analysis for their 
data needs at these local levels and for select populations 
in these areas to identify disparities and target interven-
tions and public health funding.
Methods
Data sources
 
The BRFSS is an annual random-digit–dialed survey of 
noninstitutionalized adults (≥18 years) that is funded by 
CDC and executed by health departments in every state 
and the District of Columbia (14). We used BRFSS data 
from  2000,  even  though  more  recent  BRFSS  data  are 
available, to allow temporal comparability with other data 
sources.
 
Information on county-level sociodemographic and health 
care measures came from the 2000 US Decennial Census 
(15) and the Area Resource File (16). Mammography facil-
ity data certified by the Food and Drug Administration 
(FDA) (17) provided a county-level measure of access to 
mammography facilities. We merged and linked data sets 
by BRFSS respondents’ county of residence.
Study sample
 
The analyses included women aged 40 to 79 years. An 
age  threshold  of  40  years  captured  the  most  inclusive 
screening  guidelines  provided  by  the  American  Cancer 
Society and the US Preventive Services Task Force (18,19). 
We selected an age limit of 79 years because the benefit of 
screening for older women is debatable (20,21). For these 
analyses, the age range of the BRFSS sample matched the 
age categories of the census data.
 
Of the 58,901 women aged 40 to 79 who participated in 
the 2000 BRFSS, we excluded from the analyses women 
with  missing  information  on  county  code  (n  =  14,599; 
24.8%  of  initial  sample),  who  refused  to  provide  their 
county of residence (n = 167; 0.3% of initial sample), and 
with “don’t know” or “not sure” responses to county of resi-
dence (n = 140; 0.2% of initial sample). A large percentage 
of women were missing information on county of residence 
because CDC set the county code as missing for women 
from counties with fewer than 50 observations in the 2000 
public-use BRFSS data. Thus, the final analytic sample 
included 43,995 women with valid data on mammography 
history who lived in the continental United States and had 
Federal Information Processing Standard (FIPS) county 
codes to link with census data.
Dependent variable
 
The women’s health section of the BRFSS core question-
naire included questions about breast cancer screening. 
We coded recent mammography status as a dichotomous 
variable.  Women  who  reported  having  had  a  mammo-
gram in the past 2 years were coded as recently screened. 
Women who reported never having had a mammogram 
or that their most recent mammogram was more than 2 
years ago were coded as not recently screened. We coded VOLUME 6: NO. 4
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women who answered “don’t know” or refused to answer 
the  mammography  questions  (n  =  349)  as  not  recently 
screened, consistent with other studies (5). 
Independent variables
 
A  cross-classification  of  race  (white,  black,  or  other 
nonwhite race) and age (40-49, 50-64, or 65-79 y) was the 
primary independent variable from the BRFSS data. We 
selected race and age because counties vary in sociodemo-
graphic composition across the United States (22), recent 
mammography is related to these 2 variables in bivariate 
analyses, and the same cross-classification of variables is 
possible with census data.
 
We treated Hispanic ethnicity as a confounder because 
bivariate analyses showed that the prevalence of mammog-
raphy was lower among Hispanics. Additionally, Hispanic 
ethnicity was not included in our cross-classification of race 
and age because it was not possible to use census data to 
create a cross-classification of race, ethnicity, and age for 
noninstitutionalized women aged 18 years or older.
 
We also considered county-level variables shown to be 
related to recent mammography as confounders, similar 
to variables explored by Legler et al (23). We used scat-
terplots and correlation coefficients to evaluate collinear 
relationships  among  independent  variables.  The  final 
model  included  average  per  capita  annual  household 
income (census data), number of doctors per 10,000 women 
aged 40 or older and Rural-Urban Continuum Codes (Area 
Resource File data), and number of FDA-certified mam-
mography facilities per 10,000 women aged 40 or older 
(FDA data). We coded all county-level variables as categor-
ical variables on the basis of quintiles of their distributions 
because they were linearly associated with the outcome.
Statistical analyses
 
Small-area  estimation  by  synthetic  regression  was  a 
2-step  process.  First,  we  used  generalized  estimating 
equations for logistic regression to analyze the association 
between recent mammography and the race-age variable, 
producing  a  predicted  prevalence  for  each  race-age  cat-
egory. The model accounted for the clustering of women 
by  county  and  the  complex  BRFSS  survey  design  and 
included both individual- and county-level confounders:
 
Logit (Yijk) = β0 + β1(Raceijk*Ageijk) + β2(Hispanicijk) + β3Vjk
where  Yijk  is  recent  mammography  for  women  (i)  who 
reside  in  counties  (j)  in  states  (k);  Raceijk*Ageijk  is  the 
cross-classification  of  the  race  and  age  categorical  vari-
ables for women (i) nested within counties (j) and states 
(k); Hispanicijk is Hispanic ethnicity for women (i) nested 
within counties (j) and states (k); Vjk is a vector of county 
(j)  level  variables  nested  within  the  state  (k);  β0  is  the 
population-averaged,  or  marginal,  intercept  term;  β1  is 
the population-averaged coefficient for the race*age cross-
classification;  β2  is  the  population-averaged  coefficient 
for  Hispanic  ethnicity;  and  β3  is  the  vector  of  popula-
tion-averaged  coefficients  for  county-level  variables.  We 
built separate models for each regional census division to 
account for regional effects when predicting mammogra-
phy prevalence.
 
Next, we used the resulting predicted probabilities from 
step 1 in the synthetic estimation of mammography preva-
lence to estimate the proportion of women in each county 
who  reported  recently  having  had  a  mammogram.  The 
synthetic estimate of the prevalence (pj) of recent mam-
mography for county j equaled
 
pj = ∑ (nij / nj) pij
 
where pij is the predicted probability for a specified race-
age category from step 1; nij is the number of women in 
race-age group (i) who reside in the county (j); and nj is the 
total number of women aged 40 to 79 who reside in the 
county (j). The sum of the race-age weighted prevalences 
equaled the prevalence of recent mammography for the 
county.
 
We  performed  all  statistical  analyses  by  using  SAS 
version 9 (SAS Institute, Inc, Cary, North Carolina) and 
SAS-Callable  SUDAAN  version  9.1  (Research  Triangle 
Institute,  Research  Triangle  Park,  North  Carolina)  to 
adjust  for  complex  survey  design.  We  used  small-area 
analysis to estimate the prevalence of recent mammogra-
phy in each county for women aged 40 to 79. Further, we 
repeated the procedure to estimate county-level mammog-
raphy prevalence for each race and age category to deter-
mine the extent to which geographic disparities existed 
for and differed by sociodemographic subgroups.
 
We  mapped  results  using  ArcGIS  version  9.2  (ESRI, 
Redlands,  California),  which  produced  a  visualization   
of  county-level  prevalence  to  identify  geographic  dis-
parities in screening. For the maps, the natural-breaks   VOLUME 6: NO. 4
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classification  method  determined  the  preva-
lence categories of recent mammography (24).
 
We hypothesized that county-level analyses 
would produce similar patterns in prevalence 
as found at the state level, that counties in 
the Northeast would report the highest preva-
lence of mammography, and that counties in 
the  Southeast  and  Mountain  regions  would 
report  the  lowest  prevalence.  A  prior  study 
found similar geographic patterns when using 
2002 BRFSS data to estimate prevalence of 
mammography  for  the  9  census  regions  (5). 
We posited that some intrastate variation in 
mammography prevalence would be observed 
and that the magnitude and location of these 
geographic disparities would vary by race or 
age.  We  further  hypothesized  that  counties 
with a greater proportion of younger and non-
white  women  would  have  lower  prevalence 
of mammography because these groups have historically 
had lower prevalence of mammography (25) and are not 
uniformly represented across US counties (22).
Evaluation of small-area estimates
 
Because a gold standard was unavailable, we used state-
level direct estimates to evaluate the validity of small-area 
estimates.  We  aggregated  county-level  prevalence  esti-
mates of recent mammography that were obtained from 
the small-area analysis to the state level. We also directly 
estimated  state-level  prevalence  of  recent  mammogra-
phy  by  using  2000  BRFSS  data.  State-level  aggregated 
small-area  estimates  were  compared  with  state-level 
direct prevalence estimates, and we calculated the aver-
age differences between them, as well as the 95% confi-
dence intervals (CIs). We calculated Pearson correlation 
coefficients between the 2 measures and then confirmed 
the correlations by conducting bivariate linear regression 
analyses. P values < .05 were considered significant.
Results
 
The prevalence of recent mammography in our national 
sample  of  women  aged  40  to  79  years  was  78.5%.  The 
average county-level prevalence of recent mammography 
was 77.9% (95% CI, 77.8%-78.0%) (Table 1); small-area 
estimates on the county level ranged from 69.6% to 84.0%. 
We found county prevalence estimates calculated by using 
small-area  analysis  to  be  generally  reliable.  Overall, 
99.6%  of  counties  had  95%  confidence  intervals  within 
5  percentage  points  of  the  estimates.  For  example,  the 
prevalence of recent mammography for women aged 40 
to 79 in Stephens County, Georgia, was 80.0% (95% CI, 
78.9%-81.0%). The largest confidence interval for a county-
level prevalence estimate (59.3%-79.9%) was in Shannon 
County, South Dakota.
 
The highest prevalence of mammography in our study 
sample was in the New England, North and South Atlantic, 
and  East  North  Central  census  divisions  (Figure).  The 
lowest prevalence of mammography was in the Mountain 
states  and  Texas.  Intrastate  variation  was  greatest  in 
California, where certain counties were in the lowest cat-
egory of prevalence (69.6%-74.3%) and others were in the 
highest category (≥81.6).
 
County-level prevalence estimates varied by race (race- 
and  age-specific  maps  not  shown).  For  white  race,  the 
average county-level prevalence was 78.4%, and county-
level estimates ranged from 73.8% to 84.3%. Lower-preva-
lence areas clustered in Texas and the Mountain states, 
and areas on the high end of the distribution clustered in 
the Pacific, New England, and Atlantic divisions.
 
The average county-level prevalence was 78.5% for black 
women and 67.4% for women of other nonwhite race. While 
Figure. County-level prevalence of recent mammography for women aged 40 to 79 years in 
the continental United States. Estimated by using data from the 2000 Behavioral Risk Factor 
Surveillance System and US Decennial Census. VOLUME 6: NO. 4
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the average county-level prevalence for black women was 
nearly  equal  to  the  prevalence  for  white  women,  the 
prevalence for other nonwhite women was 10 percentage 
points lower. The range in screening prevalence across US 
counties was higher for nonwhite women than for white 
women (black range, 65.0%-92.0%; other nonwhite range, 
36.0%-83.0%). For black women, counties in the Mountain 
division, upper peninsula of Michigan, and Wisconsin had 
the  lowest  prevalence  of  mammography  (65.0%-72.6%), 
and counties in the Pacific, New England, and West North 
Central  divisions  had  the  highest  prevalence  (86.8%-
92.0%). Prevalence of recent mammography was generally 
lower for other nonwhite women but was highest in coun-
ties of the East North Central and New England divisions 
(75.4%-83.0%) and lowest in counties of the South Central 
divisions (36.0%-62.9%).
 
The  average  county-level  prevalence  was  highest  for 
women aged 50 to 64 (82.3%), followed by women aged 
65 to 79 (80.7%), and then lowest for women aged 40 to 
49 (71.2%). Although women aged 40 to 49 had on aver-
age  the  lowest  county-level  prevalence  of  recent  mam-
mography,  the  largest  range  in  county-level  prevalence 
estimates was seen in women aged 65 to 79  (range, 53.0%-
88.0%). Texas, the south Mountain division, and southern 
California had the lowest screening prevalence for women 
aged 40 to 49 (56.7%-67.4%), while the New England and 
East North Central divisions had the highest prevalence 
of  mammography  for  women  in  this  age  group  (75.8%-
79.8%). Intrastate variation in prevalence existed in North 
and South Dakota. Prevalence of recent mammography 
for women aged 50 to 64 was high (75.7%-89.5%); areas 
of  highest  prevalence  were  found  in  the  New  England 
and  South  Atlantic  states  (85.1%-89.5%).  The  Southern 
California,  Mountain,  and  parts  of  the  South  Central 
divisions had the areas of lowest prevalence for this age 
group (75.7%-80.2%). Finally, the Pacific, Mountain, New 
England, and parts of the South Atlantic divisions had the 
highest  prevalence  of  recent  mammography  for  women 
aged 65 to 79 (84.0%-88.0%). Counties in the West North 
Central census division and parts of Texas had the lowest 
prevalence of mammography for women in this oldest age 
group (53.0%-77.9%).
 
On  average,  small-area  estimates  aggregated  to  the 
state level were within 2.4 percentage points of the directly 
derived state estimates of recent mammography prevalence 
from the BRFSS (range, −10.3 to 8.6) (Table 2). Aggregated 
small-area estimates were generally higher, but correlated, 
with direct estimates (ρ = 0.58; P < .001; regression β = 
0.34; P < .001). The largest difference between direct state 
estimates and aggregated small-area estimates occurred 
in Idaho, where the aggregated value overestimated the 
direct value by 10.3 percentage points. The smallest differ-
ences occurred in Kansas, New York, and North Carolina, 
where  the  aggregated  value  underestimated  the  direct 
value by 0.3 percentage points.
Discussion
 
We  demonstrated  the  value  of  small-area  analysis  in 
producing county-level prevalence estimates of mammog-
raphy for women aged 40 to 79 years. The prevalence of 
recent mammography across counties in the continental 
United States is generally high. Our findings were consis-
tent with estimates calculated for metropolitan statistical 
areas by using BRFSS data from a similar time period (9). 
Furthermore, we showed that small-area estimates aggre-
gated  to  the  state  level  were  comparable  to  state-level 
direct estimates of recent mammography prevalence.
 
Mapping of prevalence estimates showed that the loca-
tion and magnitude of screening disparities varied by race 
and  age.  County-level  prevalence  estimates  and  lower 
minimum  prevalence  values  varied  more  for  black  and 
other nonwhite women than for white women. Research 
shows substantial disparities in the quality and quantity 
of health care received by minority populations (26), and 
these disparities are disproportionately distributed across 
the  nation  (27).  Regional  variations  in  mammography 
use by race are likely due to quality of care, insurance 
coverage, and availability of health care to minority popu-
lations (28). By monitoring mammography use in minor-
ity populations and tracking these geographic variations, 
interventions aimed at improving quality and access can 
be targeted to the neediest counties (23).
 
Our  age-related  findings  may  be  likely  explained  by 
confusion  over  conflicting  screening  recommendations 
for  younger  and  older  women.  In  2000,  the  benefit  of 
mammography  for  women  younger  than  50  was  being 
debated because the reduction in breast cancer mortality 
for these women was uncertain, given their low incidence 
of cancer (19,29). Similar questions arose concerning the 
benefits  of  screening  for  older  women,  who  commonly 
have comorbidities and lower life expectancy (20,21). The 
range of prevalence estimates for women aged 40 to 49 VOLUME 6: NO. 4
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(56.7%-79.8%)  was  generally  lower  than  for  other  age 
groups, and range in county-level prevalence estimates 
was largest among women aged 65 to 79 (53.0%-88.0%). 
Women  in  these  age  categories  may  differentially  be 
recommended  for  mammography  by  clinicians  or  have 
misperceptions about their need for screening. A recent 
study  found  that  among  women  with  access  to  health 
care, nonscreeners were more likely to be younger (aged 
40-49),  and  these  younger  women  were  more  likely  to 
have postponed having a mammogram than to not real-
ize that they needed the examination (30). Additionally, 
among women aged 65 or older with access to health care, 
75% reported no mammography recommendation from a 
physician in the past year (30). Knowledge of age-related 
geographic  disparities  could  help  public  health  profes-
sionals  in  underscreened  counties  develop  programs 
targeted to 2 groups: women who might not perceive the 
benefit of mammography at their age and clinicians who 
might  not  be  recommending  or  referring  younger  and 
older women to screening.
 
Findings  showed  intrastate  variation  in  county-level 
prevalence  of  mammography.  Conducting  substate  sur-
veillance for subpopulations (eg, by race or age) to identify 
interregional  and  intrastate  differences  is  vital  to  state 
and local health officials’ understanding of who remains 
underscreened for breast cancer (9). This knowledge can 
be  used  to  design  interventions  and  formulate  policies 
to  increase  screening  in  high-risk  areas,  subsequently 
reducing rates of breast cancer mortality and late-stage 
diagnosis (31).
 
In general, we observed little variability in the small-area 
estimates for women aged 40 to 79, probably because of the 
selection of a cross-classification variable. Unfortunately, a 
race-age-sex cross-classification was the only combination 
of variables possible using publicly available census data 
for  the  noninstitutionalized  adult  population.  Previous 
studies identified race and age as determinants of screen-
ing use (32,33), but income and insurance/usual provider 
are stronger determinants of screening (34). If our cross-
classification variable could include income and insurance/
usual provider, then we would probably have seen more 
variation in small-area screening prevalences, especially 
since  the  relationship  between  income,  insurance/usual 
provider, and screening varies by region (9). Even with 
this  attenuation,  small-area  estimation  is  necessary  to 
understand geographic disparities in mammography use 
if the results are reported appropriately. The results are 
valuable  for  surveillance  purposes  and  tracking  trends 
over time because these are often the only data available 
on the substate level (35).
 
Small-area estimation was necessary because 92% of US 
counties (using 2000 BRFSS data) had insufficient sample 
size to estimate the prevalence of mammography. CDC in 
recent years has increased the sample size of the BRFSS 
to support substate or subpopulation analyses (6). From 
2000 to 2006, the number of women aged 40 to 79 who 
were interviewed increased from 62,389 to 146,156. Even 
with the BRFSS sample size increase, small-area estima-
tion methods would be needed to estimate mammography 
prevalence in 80% of US counties in 2006. CDC should con-
tinue increasing the BRFSS sample size by recommending 
target sample-size goals and providing funding to states.
 
This study has several potential biases and limitations. 
The political and conceptual definitions of county differ by 
state. In the BRFSS, the parishes, boroughs, or counties 
defined within a state are identified by using FIPS county 
codes. However, public health departments, outreach, and 
interventions do not occur on these levels in all states. 
For  example,  some  states,  such  as  Rhode  Island,  have 
regional or state health departments rather than county 
health  departments,  and  thus  county  data  mean  little 
or nothing in terms of public health activities in these 
states.  These  different  meanings  of  “county”  may  have 
introduced  random  error  into  our  results.  Additionally, 
questions on the BRFSS do not allow differentiation of 
screening mammograms from diagnostic mammograms; 
thus,  BRFSS  data  may  overestimate  the  prevalence  of 
screening mammography.
 
This study excluded 14,906 women with no information 
on  FIPS  county  code  to  link  with  census  data  because 
CDC did not include county code in the BRFSS for people 
residing  in  counties  with  fewer  than  50  observations. 
The purpose is to prevent the public from analyzing and 
reporting prevalence estimates for counties with inade-
quate sample size. In our exploratory analyses, compared 
with included women, women excluded from the analyses 
were more likely to be non-Hispanic white, married, and 
educated (college graduates). While it is uncertain how 
our small-area estimates would differ with the inclusion 
of these women, the estimates would probably be slightly 
higher because education, marriage, and white race are 
all positively associated with mammography use (2).VOLUME 6: NO. 4
OCTOBER 2009
  www.cdc.gov/pcd/issues/2009/oct/08_0210.htm • Centers for Disease Control and Prevention  7
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
Finally, data collected for the BRFSS are self-reported. 
Research generally shows self-reported cancer screening 
history  to  be  valid  (36).  However,  mammography  was 
found to be overreported in the BRFSS by racial/ethnic 
minority women when Medicare claims data were used as 
the standard (37), and thus BRFSS-derived prevalence of 
mammography for minority women may be overestimated. 
Furthermore,  prior  studies  found  that  women  tend  to 
underestimate time since their last mammogram (“tele-
scoping”), which could also contribute to overestimation of 
BRFSS data (38).
 
In conclusion, small-area estimation using BRFSS data 
is  advantageous  for  surveillance  of  mammography  at 
the  county  level.  This  method  allowed  us  to  document 
geographic  disparities  and  improve  knowledge  of  the 
spatial distribution of mammography prevalence. Future 
interventions should consider this county-level geographic 
variation to target women in the neediest counties.
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Tables
Table 1. County-Level Prevalence Estimates of 
Mammography Produced From Small-Area Estimation by 
Using BRFSS and Census Data, Women Aged 40-79 Years, 
by Race and by Age, Contiguous United States, 2000
Category
Meana County-level 
Prevalence, % (95% CI)
Range of County-level 
Prevalence, %
Overall 77.9 (77.8-78.0) 69.6-84.0
Race
White 78.4 (78.4-78.) 7.8-84.
Blackb 78. (78.4-78.6) 6.0-92.0
Other nonwhitec 67.4 (67.2-67.7) 6.0-8.0
Age, y
40-49 71.2 (71.0-71.) 6.7-79.8
0-64 82. (82.2-82.) 7.7-89.
6-79 80.7 (80.6-80.8) .0-88.0
 
Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System; CI, confi-
dence interval. 
a Mean and median of county-level prevalence were <2 percentage points 
different. 
b Three hundred forty-two counties had no black population for which to esti-
mate prevalence. 
c Four counties had no other nonwhite race population for which to estimate 
prevalence. 
Table 2. Comparison of Directly Estimated State Prevalence 
of Recent Mammography for Women Aged 40-79 Years 
With County-Level Small-Area Estimates Aggregated to the 
State Level, BRFSS, Contiguous United States, 2000 
State
Direct 
Estimates, %
Aggregated 
Small-area 
Estimates, %
Percentage 
Point 
Difference
Alabama 76. 77.6 −1.3
Arizona 80.9 76.6 4.
Arkansas 7.8 7.6 −1.8
California 78.6 77. 1.
Colorado 7.4 76.2 −0.8
Connecticut 84.8 8. 1.
Delaware 88.0 79.4 8.6
District of Columbia 82.0 78.2 .8
Florida 78.9 79.9 −1.0
Georgia 77.4 79. −1.9
Idaho 66.4 76.7 −10.3
Illinois 77.0 79.6 −2.6
Indiana 74. 79.6 −5.3
Iowa 79.6 77.7 1.9
Kansas 77.8 77. 0.
Kentucky 77.8 77.1 0.6
Louisiana 76.9 7.2 1.8
Maine 79.9 8.8 −3.9
Maryland 82.0 79.1 2.9
Massachusetts 84.9 8.4 1.
Michigan 8.7 79.6 4.2
Minnesota 7.4 77. −2.1
Mississippi 7. 77.8 −4.3
Missouri 77.2 77.8 −0.6
Montana 76.2 76.7 −0.5
Nebraska 79.7 77.6 2.1
Nevada 74.1 76. −2.4
New Hampshire 78.7 8.7 −5.0
New Jersey 77.4 79.4 −2.0
 
Abbreviation: BRFSS, Behavioral Risk Factor Surveillance System. 
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State
Direct 
Estimates, %
Aggregated 
Small-area 
Estimates, %
Percentage 
Point 
Difference
New Mexico 77.0 76.2 0.8
New York 80. 80.0 0.
North Carolina 79.7 79.4 0.
North Dakota 78.6 77. 1.2
Ohio 82.1 79.6 2.
Oklahoma 72.8 74.2 −1.4
Oregon 77. 78.7 −1.2
Pennsylvania 78.9 80.2 −1.3
Rhode Island 84.6 8. 1.1
South Carolina 79.8 79. 0.
South Dakota 77.2 76.8 0.4
Tennessee 78. 77. 1.2
Texas 72.6 74. −1.9
Utah 74. 76. −2.0
Vermont 79.0 8.7 −4.7
Virginia 81.2 79.4 1.8
Washington 77. 78. −1.0
West Virginia 72.7 79.9 −7.1
Wisconsin 79.2 79. −0.4
Wyoming 67.8 76.4 −8.6
 
Abbreviation: BRFSS, Behavioral Risk Factor Surveillance System. 
Table 2. (continued) Comparison of Directly Estimated 
State Prevalence of Recent Mammography for Women 
Aged 40-79 Years With County-Level Small-Area Estimates 
Aggregated to the State Level, BRFSS, 2000 